Literature DB >> 33260510

Effect of Plasma-Treatment of Interleaved Thermoplastic Films on Delamination in Interlayer Fibre Hybrid Composite Laminates.

Salvatore Giacomo Marino1, Florian Mayer2, Alexander Bismarck2,3, Gergely Czél1.   

Abstract

Safe, light, and high-performance engineering structures may be generated by adopting composite materials with stable damage process (i.e., without catastrophic delamination). Interlayer hybrid composites may fail stably by suppressing catastrophic interlayer delamination. This paper provides a detailed analysis of delamination occurring in poly(acrylonitrile-butadiene-styrene) (ABS) or polystyrene (PS) film interleaved carbon-glass/epoxy hybrid composites. The ABS films toughened the interfaces of the hybrid laminates, generating materials with higher mode II interlaminar fracture toughness (GIIC), delamination stress (σdel), and eliminating the stress drops observed in the reference baseline material, i.e., without interleaf films, during tensile tests. Furthermore, stable behaviour was achieved by treating the ABS films in oxygen plasma. The mechanical performance (GIIC and σdel) of hybrid composites containing PS films, were initially reduced but increased after oxygen plasma treatment. The plasma treatment introduced O-C=O and O-C-O-O functional groups on the PS surfaces, enabling better epoxy/PS interactions. Microscopy analysis provided evidence of the toughening mechanisms, i.e., crack deflection, leading plasma-treated PS to stabilise delamination.

Entities:  

Keywords:  delamination; fibre hybrid composites; film-interleaving; fracture toughness; plasma-treatment

Year:  2020        PMID: 33260510     DOI: 10.3390/polym12122834

Source DB:  PubMed          Journal:  Polymers (Basel)        ISSN: 2073-4360            Impact factor:   4.329


  1 in total

1.  Stitching Repair for Delaminated Carbon Fiber/Bismaleimide Composite Laminates.

Authors:  Jiantao Hua; Suli Xing; Shaohang An; Dingding Chen; Jun Tang
Journal:  Polymers (Basel)       Date:  2022-08-29       Impact factor: 4.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.